Healthcare provider profile · identity verified

Militza Canino Rivera, MD

General Practice · HUMACAO, PR · NPI 1629185749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	739	110
Famotidine	Famotidine	655	95
Gabapentin	Gabapentin	593	76
Levothyroxine Sodium	Levothyroxine Sodium	554	68
Simvastatin	Simvastatin	441	62
Lisinopril	Lisinopril	424	61
Alendronate Sodium	Alendronate Sodium	369	50
Doxazosin Mesylate	Doxazosin Mesylate	315	35
Synthroid	Levothyroxine Sodium	315	43
Donepezil Hcl	Donepezil Hcl	302	38
Metformin Hcl	Metformin Hcl	259	39
Clopidogrel	Clopidogrel Bisulfate	236	31
Furosemide	Furosemide	236	32
Tizanidine Hcl	Tizanidine Hcl	234	51
Amlodipine Besylate	Amlodipine Besylate	223	31
Losartan Potassium	Losartan Potassium	211	32
Memantine Hcl	Memantine Hcl	206	26
Irbesartan	Irbesartan	187	26
Sertraline Hcl	Sertraline Hcl	174	26
Ezetimibe	Ezetimibe	153	30
Hydralazine Hcl	Hydralazine Hcl	149	20
Carvedilol	Carvedilol	139	16
Rosuvastatin Calcium	Rosuvastatin Calcium	131	29
Atenolol	Atenolol	128	15
Tamsulosin Hcl	Tamsulosin Hcl	120	17
Metoprolol Succinate	Metoprolol Succinate	112	16
Glipizide Er	Glipizide	108	15
Baclofen	Baclofen	101	15
Glimepiride	Glimepiride	101	15
Lantus	Insulin Glargine,hum.Rec.Anlog	101	13
Eliquis	Apixaban	96	15
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	96	18
Pentoxifylline	Pentoxifylline	96	14
Metoprolol Tartrate	Metoprolol Tartrate	94	11
Spironolactone	Spironolactone	94	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	91	37
Xarelto	Rivaroxaban	90	13
Farxiga	Dapagliflozin Propanediol	88	15
Meclizine Hcl	Meclizine Hcl	87	21
Allopurinol	Allopurinol	83	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	80	suppressed
Glycopyrrolate	Glycopyrrolate	76	18
Bumetanide	Bumetanide	73	suppressed
Clonazepam	Clonazepam	73	17
Hydrochlorothiazide	Hydrochlorothiazide	72	12
Enalapril Maleate	Enalapril Maleate	71	suppressed
Fluticasone Propionate	Fluticasone Propionate	66	27
Lansoprazole	Lansoprazole	66	suppressed
Levetiracetam	Levetiracetam	62	suppressed
Glipizide	Glipizide	61	suppressed
Sucralfate	Sucralfate	61	11
Oxybutynin Chloride Er	Oxybutynin Chloride	60	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	60	11
Finasteride	Finasteride	56	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	56	44
Temazepam	Temazepam	54	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	51	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	suppressed
Nifedipine Er	Nifedipine	49	suppressed
Diclofenac Sodium	Diclofenac Sodium	48	15
Etodolac	Etodolac	43	suppressed
Lovastatin	Lovastatin	42	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	39	13
Lactulose	Lactulose	38	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	37	suppressed
Novolog	Insulin Aspart	37	suppressed
Omeprazole	Omeprazole	37	suppressed
Naproxen Sodium	Naproxen Sodium	36	16
Janumet Xr	Sitagliptin Phos/Metformin Hcl	35	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Methylprednisolone	Methylprednisolone	32	28
Insulin Syringe	Syringe And Needle,insulin,1ml	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Risperidone	Risperidone	31	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Ketoconazole	Ketoconazole	30	16
Jardiance	Empagliflozin	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	25
Isosorbide Dinitrate	Isosorbide Dinitrate	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Rivastigmine	Rivastigmine	26	suppressed
Rivastigmine	Rivastigmine Tartrate	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Dilantin	Phenytoin Sodium Extended	25	suppressed
Naproxen	Naproxen	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Primidone	Primidone	24	suppressed
Betamethasone Valerate	Betamethasone Valerate	23	suppressed
Cefadroxil	Cefadroxil	23	22
Memantine Hcl Er	Memantine Hcl	23	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Levofloxacin	Levofloxacin	21	20
Sulindac	Sulindac	21	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	21	suppressed
Azithromycin	Azithromycin	20	17
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	19	suppressed
Cilostazol	Cilostazol	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	19	suppressed
Enulose	Lactulose	18	suppressed
Fluocinonide	Fluocinonide	18	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Permethrin	Permethrin	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valsartan	Valsartan	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Letrozole	Letrozole	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	14	suppressed
Lagevrio (Eua)	Molnupiravir	14	14
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Risedronate Sodium	Risedronate Sodium	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Glipizide Xl	Glipizide	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Trazodone Hcl	Trazodone Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	11
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Trulance	Plecanatide	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Metolazone	Metolazone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error